Central Bank & Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-22
Closed -$5.28K – 435
2022
Q4
$5.28K Buy
+22
New +$4.93K ﹤0.01% 311
2022
Q3
– Sell
-106
Closed -$18K – 321
2022
Q2
$18K Sell
106
-190
-64% -$40.8K ﹤0.01% 263
2022
Q1
$74K Hold
296
– – 0.01% 214
2021
Q4
$76K Hold
296
– – 0.01% 210
2021
Q3
$72K Hold
296
– – 0.01% 206
2021
Q2
$61K Buy
296
+211
+248% +$43K 0.01% 207
2021
Q1
$16K Buy
+85
New +$15K ﹤0.01% 250
2018
Q3
– Sell
-115
Closed -$12K – 266
2018
Q2
$12K Sell
115
-60
-34% -$6.07K ﹤0.01% 223
2018
Q1
$17K Buy
+175
New +$17K ﹤0.01% 207

Other funds holding HCA

Central Bank & Trust's HCA Position: Q1 2023 in Review

Central Bank & Trust sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 22 shares — an estimated $5.28K sold.

Central Bank & Trust first reported a position in HCA in Q1 2018 and held it in 9 quarters. The position peaked at $76K in Q4 2021. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Central Bank & Trust reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Central Bank & Trust sold 22 HCA Healthcare shares in Q1 2023, an estimated $5.28K.
  • Central Bank & Trust first reported a position in HCA Healthcare in Q1 2018 and held it in 9 quarters.
  • Central Bank & Trust's HCA Healthcare position peaked at $76K in Q4 2021.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Central Bank & Trust's 13F filing for Q1 2023, filed 13 Apr 2023.